2018 Pan Pacific Lymphoma Conference
S

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

By 2018 Pan Pacific Lymphoma Conference FEATURING Stephen M. Ansell
08/2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
The University of Kansas Cancer Center

Hematology & Medical Oncology Review 2019

Sat, Jun 29, 2019
European School of Oncology

Lymphoma

Sat, Jun 15, 2019
16:03
2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro
09:59
2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

Feat. J. Gribben
12:42
Loretta Nastoupil

Checkpoint Inhibitors in Hodgkin Lymphoma: When and How

24:35
Stephen M. Ansell

Hodgkin Lymphoma - Immunotherapy

12:31
Indy Hematology Review

Emerging Strategies and Treatment in Hodgkin Lymphoma

Feat. B. Cheson
05:16
Loretta Nastoupil

Combination Immunotherapy for Checkpoint Inhibitors in Lymphoma Immunoth...

24:22
Cleveland Clinic Orthopaedic & Rheumatologic Institute

Autoimmune Complications from Cancer Chemotherapy: An Emerging Field

Feat. L. Cappelli
27:00
Craig Moskowitz

Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role of ...

08:16
2018 Pan Pacific Lymphoma Conference

How Can We Activate the Anti-tumor Immune Response in Lymphoma?

Feat. S. Ansell
15:07
2018 Pan Pacific Lymphoma Conference

Immune Evasion and Engagement in Lymphoma: The Mechanisms of Impairment ...

Feat. S. Ansell
06:44
2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma: First Relapse Options

Feat. B. Pro
09:59
2018 Pan Pacific Lymphoma Conference

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

Feat. C. Moskowitz
17:13
Catherine Diefenbach

Beyond transplant: Relapsed and Refractory Hodgkin Lymphoma

15:47
2018 Pan Pacific Lymphoma Conference

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymphoma

Feat. C. Moskowitz
09:35
Catherine Diefenbach

Immunotherapy in Relapsed Refractory Hodgkin Lymphoma

07:10
Society of Hematologic Oncology Sixth Annual Meeting

Oral Abstract SCT 020: Incidence, Risk Factors and Treatment Response in...

Feat. D. Rivera
20:25
2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lymphoma

Feat. R. Hoppe
16:03
2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro
09:59
2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

Feat. J. Gribben
12:42
Loretta Nastoupil

Checkpoint Inhibitors in Hodgkin Lymphoma: When and How